CIK 0001703647
- Non-accelerated filer
- Smaller reporting company
Korro Bio, Inc.
Sign in to watch- Ticker
- KRRO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472324450
- Phone
- +1 617-468-1999
- Business address
- 60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
- Former names
- Frequency Therapeutics, Inc.
- Open-market buys, last 90 days
- $884,752
- in 1 filing
- Open-market sales, last 90 days
- $1,763,410
- in 5 filings, $1.8M under 10b5-1 plans
Net −$878,658. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-07 | Lucchino David L. President and CEO | Sale 10b5-1 | −2,857 | $0.68 | $2K | 661,935 |
| 2023-08-07 | Mitrano Richard J. VP Finance & Operations | Sale 10b5-1 | −235 | $0.69 | $162 | 50,817 |
| 2023-08-04 | Lucchino David L. President and CEO | Sale 10b5-1 | −2,550 | $0.69 | $2K | 664,792 |
| 2023-08-04 | Mitrano Richard J. VP Finance & Operations | Sale 10b5-1 | −220 | $0.67 | $147 | 51,052 |
| 2023-08-03 | Lucchino David L. President and CEO | Sale 10b5-1 | −2,679 | $0.59 | $2K | 667,342 |
| 2023-08-03 | Mitrano Richard J. VP Finance & Operations | Sale 10b5-1 | −232 | $0.56 | $130 | 51,272 |
| 2023-08-02 | Lucchino David L. President and CEO | Sale 10b5-1 | −2,587 | $0.52 | $1K | 670,021 |
| 2023-08-02 | Mitrano Richard J. VP Finance & Operations | Sale 10b5-1 | −231 | $0.49 | $113 | 51,504 |
| 2023-08-01 | Lucchino David L. President and CEO | Sale 10b5-1 | −2,799 | $0.49 | $1K | 672,608 |
| 2023-08-01 | Mitrano Richard J. VP Finance & Operations | Sale 10b5-1 | −238 | $0.48 | $114 | 51,735 |
| 2023-07-31 | Lucchino David L. President and CEO | Sale 10b5-1 | −2,676 | $0.50 | $1K | 675,407 |
| 2023-07-31 | Mitrano Richard J. VP Finance & Operations | Sale 10b5-1 | −222 | $0.50 | $111 | 51,973 |
| 2023-07-28 | Mitrano Richard J. VP Finance & Operations | Sale 10b5-1 | −223 | $0.47 | $105 | 52,195 |
| 2023-07-28 | Lucchino David L. President and CEO | Sale 10b5-1 | −2,647 | $0.47 | $1K | 678,083 |
| 2023-07-28 | Loose Christopher R. Chief Scientific Officer | Sale 10b5-1 | −1,344 | $0.46 | $618 | 183,650 |
| 2023-07-27 | Mitrano Richard J. VP Finance & Operations | Sale 10b5-1 | −227 | $0.53 | $120 | 52,418 |
| 2023-07-27 | Lucchino David L. President and CEO | Sale 10b5-1 | −2,791 | $0.51 | $1K | 680,730 |
| 2023-07-27 | Loose Christopher R. Chief Scientific Officer | Sale 10b5-1 | −1,373 | $0.53 | $728 | 184,994 |
| 2023-07-26 | Mitrano Richard J. VP Finance & Operations | Sale 10b5-1 | −222 | $0.53 | $118 | 52,645 |
| 2023-07-26 | Loose Christopher R. Chief Scientific Officer | Sale 10b5-1 | −1,329 | $0.51 | $678 | 186,367 |
Page 11 of 23 · 441 trades